Introduction
Although the current leading cause of human disease and death has shifted from infectious and parasitic diseases to chronic non-communicable and degenerative diseases according to the theory of epidemiological transition,1 as some scholars have pointed out, this shift should not obscure the ongoing threat posed by infectious diseases.2 In recent decades, outbreaks of new infectious diseases have occurred in some regions of the world. New infectious diseases are daunting due to their unexpected appearance and rapid spread.3 Severe outbreaks of new infectious diseases often become public health emergencies, even international ones, such as the outbreak of severe acute respiratory syndrome (SARS) in 2003,4 the influenza (H1N1) pandemic in 2009,5 the Ebola virus in 2014–2016,6 the Zika virus in 20167 and COVID-19 recognised by the WHO as a public health emergency of international concern (PHEIC) in March 2020.8
This COVID-19 pandemic is a global public health and safety challenge, and the crisis has brought disruptive effects on health, social, economic, political and even cultural macroscopic areas. A UN framework for the immediate socioeconomic response to COVID-19 states that the COVID-19 pandemic is not just only a health crisis, but is also affecting the social and economic core and that while the extent of the pandemic varies from country to country, it is likely to increase poverty and inequality globally and affect the achievement of the Sustainable Development Goals.9 Studies have shown that middle-aged and older adults are undoubtedly vulnerable to this pandemic event due to their higher susceptibility to COVID-19 and the risk of death and secondary disease following infection,10–13 people aged 50 and above in some countries were more likely to have medical services postponed14 and were more likely than younger adults to experience impairment in general,15 as well as their relatively lower resilience to other life and behavioural effects beyond infection in the pandemic.16 17 Are middle-aged and older adults experiencing a shortage of health services due to the global COVID-19 pandemic in the context of the large number of health resources that have to be devoted to prevention and treatment in response to the event of an outbreak? This is an important issue for policymakers and medical services professionals in the demographic context of increasing global ageing, which is crucial for targeting medical services to the middle-aged and older population, promoting the rehabilitation of geriatric diseases and preventing middle-aged and older adults from falling into a vicious cycle of increased disease susceptibility due to unmet medical needs.
Some previous studies have reported a decline in medical services utilisation among middle-aged and older patients without coronavirus after COVID-19. In Europe, a study showed substantial increases in the number of avoidable cancer deaths in England as a result of diagnostic delays due to the COVID-19 pandemic in the UK.18 In Asia, middle-aged and older Singaporeans’ healthcare utilisation and the diagnosis of chronic conditions substantially decreased among non-COVID-19 patients during the first peak period of the COVID-19 outbreak.19 A study in Japan showed that the total number of hospitalisations and outpatient visits decreased by 27% and 22%,20 respectively, after the first wave of COVID-19. Studies assessing the effect of the COVID-19 pandemic on health services utilisation in China showed that health facility visits were observed significant reduction and the impact still existed 2 years later.21 22 A study in Hong Kong, China, showed that the number of missed medical appointments among older adults during COVID-19 increased from 16.5% a year ago to 22.0% after the outbreak.23 Studies in Latin America showed a similar pattern that a majority (83%) of patient advocacy organisations reported their patients experienced delays in receiving their treatment and care services.24 And the same is true with many multicountry analyses. A study including six low-income and middle-income countries, such as Zimbabwe, showed that people with disabilities experienced additional difficulties accessing healthcare during the pandemic.25 And a review summarising literature from Africa, Australia and New Zealand, China, Europe, Latin America and the USA showed that individuals with rheumatic diseases during the pandemic faced disruptions in healthcare and medication supply shortages.26 However, many of these studies rely on small local samples or people with certain diseases and do not explore whether the decline in service utilisation is a result of reduced or unmet demand. Additionally, most studies only observe changes in outcomes before and after the pandemic, without differentiating whether these changes are specifically attributed to the effects of the pandemic or reflect general temporal trends over the same period due to other factors.
Given this, this study employed the global pandemic of COVID-19 as a quasiexperiment, combined with international large-scale survey data, to estimate the impact of the pandemic on the medical services utilisation of middle-aged and older adults worldwide. By constructing difference-in-difference (DID) models that considered both exposure time and severity, the study aims to provide robust evidence regarding the imbalances in medical services during public health emergencies. The findings would offer valuable insights for policymakers and healthcare practitioners, enabling them to avoid neglecting and proactively address the utilisation of routine medical resources for middle-aged and older individuals in future pandemics. This facilitates the development of comprehensive and targeted contingency plans to effectively tackle population health challenges arising from global public health emergencies, including infectious disease outbreaks.